Literature DB >> 5071703

Immunodiagnosis of cancer.

E J Field, E A Caspary, R T Shepherd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5071703      PMCID: PMC1785957          DOI: 10.1136/bmj.3.5827.641

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Some biological properties of a highly active encephalitogenic factor isolated from human brain.

Authors:  E J FIELD; E A CASPARY; E J BALL
Journal:  Lancet       Date:  1963-07-06       Impact factor: 79.321

2.  Is maternal lymphocyte sensitisation passed to the child?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

3.  Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds.

Authors:  E J Field; E A Caspary; P R Carnegie
Journal:  Nature       Date:  1971-09-24       Impact factor: 49.962

4.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

5.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

Review 6.  The clinical significance of mediators of cellular immunity.

Authors:  D C Dumonde; R N Maini
Journal:  Clin Allergy       Date:  1971-03

7.  Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-06-12

8.  Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor.

Authors:  E J Field; E A Caspary
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

  8 in total
  6 in total

1.  The chemical nature of cancer basic protein.

Authors:  J P Dickinson; E A Caspary
Journal:  Br J Cancer Suppl       Date:  1973-08

2.  Dysphagia and sarcoid granulomas.

Authors:  G A MacGregor
Journal:  Br Med J       Date:  1972-10-14

3.  [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].

Authors:  C Tautz; W Schneider; E Laier; G Brügmann
Journal:  Klin Wochenschr       Date:  1978-02-15

4.  Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.

Authors:  D J Flavell; A Singer; C W Potter
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

5.  Cellular immunity to encephalitogenic factor as measured by macrophage migration inhibition during tumour induction and growth.

Authors:  D J Flavell; J Goepel; C W Potter; I Carr
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

6.  Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.